RT Journal Article
SR Electronic
T1 Finding useful biomarkers for Parkinson’s disease
JF Science Translational Medicine
FD American Association for the Advancement of Science
SP eaam6003
DO 10.1126/scitranslmed.aam6003
VO 10
IS 454
A1 Chen-Plotkin, Alice S.
A1 Albin, Roger
A1 Alcalay, Roy
A1 Babcock, Debra
A1 Bajaj, Vikram
A1 Bowman, Dubois
A1 Buko, Alex
A1 Cedarbaum, Jesse
A1 Chelsky, Daniel
A1 Cookson, Mark R.
A1 Dawson, Ted M.
A1 Dewey, Richard
A1 Foroud, Tatiana
A1 Frasier, Mark
A1 German, Dwight
A1 Gwinn, Katrina
A1 Huang, Xuemei
A1 Kopil, Catherine
A1 Kremer, Thomas
A1 Lasch, Shirley
A1 Marek, Ken
A1 Marto, Jarrod A.
A1 Merchant, Kalpana
A1 Mollenhauer, Brit
A1 Naito, Anna
A1 Potashkin, Judith
A1 Reimer, Alyssa
A1 Rosenthal, Liana S.
A1 Saunders-Pullman, Rachel
A1 Scherzer, Clemens R.
A1 Sherer, Todd
A1 Singleton, Andrew
A1 Sutherland, Margaret
A1 Thiele, Ines
A1 van der Brug, Marcel
A1 Van Keuren-Jensen, Kendall
A1 Vaillancourt, David
A1 Walt, David
A1 West, Andrew
A1 Zhang, Jing
YR 2018
UL http://stm.sciencemag.org/content/10/454/eaam6003.abstract
AB The recent advent of an “ecosystem” of shared biofluid sample biorepositories and data sets will focus biomarker efforts in Parkinson’s disease, boosting the therapeutic development pipeline and enabling translation with real-world impact.